Trial Information

Summary: Pilot Study of Dose Adjustment of Vinorelbine in Patients with Varying Degree of Liver Dysfunction

The purpose of this research study is 1) to evaluate the safety and dose tolerance of the chemotherapy drug, vinorelbine in patients who have cancer for which there is no standard therapy or for which standard therapy would need to be modified due to impaired liver function.

Patient Inclusion/Exclusion Criteria:

- At least 18 years of age - Have solid tumor that is resistance to standard therapy or for which no standard therapy exists - No chemotherapy or radiation therapy in past 3 weeks - Patient must be in otherwise generally good health
- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: October 6, 2008 at 2:28:24 PM